Copyright
©The Author(s) 2021.
World J Gastroenterol. Apr 14, 2021; 27(14): 1435-1450
Published online Apr 14, 2021. doi: 10.3748/wjg.v27.i14.1435
Published online Apr 14, 2021. doi: 10.3748/wjg.v27.i14.1435
Figure 2 Effect of cyanidin 3-glucoside at different doses (10, 15 and 20 mg/kg/d) in rats.
A: Alanine aminotransferase; B: Total bilirubin; C: Direct bilirubin; D: Serum albumin. Values are mean ± SEM; number of animals = 6 rats/each group. bP < 0.05 significant differences compared to precancerous lesion group; cP < 0.05 significant differences between the 2 selected groups, One-way ANOVA followed by Tukey’s test. PCL: Precancerous lesion; Cyan: Cyanidin-3-O-glucoside; ALT: Alanine aminotransferase.
- Citation: Matboli M, Hasanin AH, Hussein R, El-Nakeep S, Habib EK, Ellackany R, Saleh LA. Cyanidin 3-glucoside modulated cell cycle progression in liver precancerous lesion, in vivo study. World J Gastroenterol 2021; 27(14): 1435-1450
- URL: https://www.wjgnet.com/1007-9327/full/v27/i14/1435.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i14.1435